These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35001789)
1. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery. Feng LH; Su T; Lu Y; Ren S; Huang L; Qin X; Liao T Scand J Gastroenterol; 2022 May; 57(5):581-588. PubMed ID: 35001789 [TBL] [Abstract][Full Text] [Related]
2. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384 [TBL] [Abstract][Full Text] [Related]
3. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study. Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058 [TBL] [Abstract][Full Text] [Related]
4. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Xie S; Li L; Wang X; Li L Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms. Liao T; Su T; Huang L; Li B; Feng LH Scand J Gastroenterol; 2022 Jan; 57(1):85-90. PubMed ID: 34592854 [TBL] [Abstract][Full Text] [Related]
7. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms]. Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463 [No Abstract] [Full Text] [Related]
8. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery. Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer. Fan S; Li T; Zhou P; Peng Q; Zhu Y Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms. Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026 [TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer. Wang S; Liu Y; Shi Y; Guan J; Liu M; Wang W J Int Med Res; 2021 May; 49(5):3000605211015023. PubMed ID: 33990147 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database. Nie D; Zheng H; An G; Li J J Cancer Res Clin Oncol; 2023 Sep; 149(11):8593-8603. PubMed ID: 37097391 [TBL] [Abstract][Full Text] [Related]
14. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237 [TBL] [Abstract][Full Text] [Related]
15. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors. Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202 [TBL] [Abstract][Full Text] [Related]
16. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study. Li X; Fan Y; Tong J; Lou M Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852 [TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma. He Y; Liu H; Wang S; Chen Y PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma. Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study. Wu C; Wang N; Zhou H; Wang T; Zhao D Saudi J Gastroenterol; 2019; 25(4):236-244. PubMed ID: 30719999 [TBL] [Abstract][Full Text] [Related]
20. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study. Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]